Hims/Hers Hims/Hers is one of the most recognizable names in telehealth, and their entry into the GLP-1 weight loss space carries the weight of a publicly traded company with millions of users
If someone is insulin resistant, has sleep apnea risk, edema tendencies, or a cancer history, you dont treat this like a casual supplement decision
Thus exendin(939)amide is also a potent inhibitor of GIP-stimulated insulin release at concentrations achieved following administration of high doses of the antagonist in vivo
In people who take many other medicines, especially those that affect the liver, careful monitoring becomes even more important
GLP-1 for Weight Loss: How It Works GLP-1 for weight loss medications work with your body, not against it
Armed with data from two successful Phase III trials, the company plans to apply for approval from the Food and Drug Administration, with a decision on the drug expected next year